Hooman Djaladat1, Elizabeth Burner2, Pooja M Parikh3, Dorsa Beroukhim Kay4, Krystal Hays3. 1. Institute of Urology, University of Southern California , Los Angeles, California. 2. Department of Emergency Medicine, University of Southern California , Los Angeles, California. 3. Department of Preventive Medicine, Keck School of Medicine, University of Southern California , Los Angeles, California. 4. Division of Biokinesiology and Physical Therapy, School of Dentistry, University of Southern California , Los Angeles, California.
Abstract
Purpose: Testicular germ cell tumors (TGCT) are the most common solid organ malignancy in young men. It is a largely curable disease, so the extent to which it affects quality of life-including male fertility-is important. Abnormal semen analysis is highly predictive of male infertility. We conducted a systematic review of published studies that reported pre-orchiectomy semen parameters (as a surrogate for fertility) in TGCT patients to evaluate the association between TGCT and semen abnormalities before orchiectomy. Methods: We conducted a systematic review of peer-reviewed publications reporting semen parameters before orchiectomy in adult patients diagnosed with TGCT. Further, we assessed the association between TGCT and semen abnormalities that may lead to infertility. Results: We applied MeSH search terms to four online databases (PubMed, Cochrane Reviews, Web of Science, and Ovid), resulting in 701 potentially relevant citations. After conducting a three-stage screening process, six articles were included in the systematic review. For each study, the participants' data and the study's quality and risk of bias were assessed and described. All studies showed semen abnormalities-including count, motility, and morphology-in men with TGCT prior to orchiectomy. Conclusions: TGCT is associated with semen abnormalities before orchiectomy. This review shows an increase in abnormal semen parameters among men with TGCT even outside the treatment effects of orchiectomy, radiation, or chemotherapy. To improve long-term quality of life, these findings should be considered when counseling patients on future fertility and sperm banking during discussions about treatment and prognosis for TGCT.
Purpose: Testicular germ cell tumors (TGCT) are the most common solid organ malignancy in young men. It is a largely curable disease, so the extent to which it affects quality of life-including male fertility-is important. Abnormal semen analysis is highly predictive of male infertility. We conducted a systematic review of published studies that reported pre-orchiectomy semen parameters (as a surrogate for fertility) in TGCT patients to evaluate the association between TGCT and semen abnormalities before orchiectomy. Methods: We conducted a systematic review of peer-reviewed publications reporting semen parameters before orchiectomy in adult patients diagnosed with TGCT. Further, we assessed the association between TGCT and semen abnormalities that may lead to infertility. Results: We applied MeSH search terms to four online databases (PubMed, Cochrane Reviews, Web of Science, and Ovid), resulting in 701 potentially relevant citations. After conducting a three-stage screening process, six articles were included in the systematic review. For each study, the participants' data and the study's quality and risk of bias were assessed and described. All studies showed semen abnormalities-including count, motility, and morphology-in men with TGCT prior to orchiectomy. Conclusions: TGCT is associated with semen abnormalities before orchiectomy. This review shows an increase in abnormal semen parameters among men with TGCT even outside the treatment effects of orchiectomy, radiation, or chemotherapy. To improve long-term quality of life, these findings should be considered when counseling patients on future fertility and sperm banking during discussions about treatment and prognosis for TGCT.
Entities:
Keywords:
fertility; germ cell tumor; orchiectomy; semen analysis; testicular cancer
Authors: A Van Steirteghem; P Nagy; H Joris; C Janssenswillen; C Staessen; G Verheyen; M Camus; H Tournaye; P Devroey Journal: Hum Reprod Date: 1998-04 Impact factor: 6.918
Authors: J Roan Spermon; Lambertus A L M Kiemeney; Eric J H Meuleman; Liliana Ramos; Alex M M Wetzels; J Alfred Witjes Journal: Fertil Steril Date: 2003-06 Impact factor: 7.329
Authors: Joshua A Halpern; Nannan Thirumavalavan; Taylor P Kohn; Amir S Patel; Joon Yau Leong; Raimondo M Cervellione; David J B Keene; Emad Ibrahim; Nancy L Brackett; Dolores J Lamb; Ranjith Ramasamy Journal: Urology Date: 2019-02-13 Impact factor: 2.649
Authors: Noa Shani Shrem; Lori Wood; Robert J Hamilton; Kopika Kuhathaas; Piotr Czaykowski; Matthew Roberts; Andrew Matthew; Jason P Izard; Peter Chung; Lucia Nappi; Jennifer Jones; Denis Soulières; Armen Aprikian; Nicholas Power; Christina Canil Journal: Can Urol Assoc J Date: 2022-08 Impact factor: 2.052
Authors: Jessica L H Walters; Bart M Gadella; Jessie M Sutherland; Brett Nixon; Elizabeth G Bromfield Journal: J Clin Med Date: 2020-01-23 Impact factor: 4.241